Goldsmith Mark A: insider trades.
Goldsmith Mark A reported 21 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 20 sales ($20.8M), across 1 company.
- Transactions
- 21
- Purchases (P)
- 0
- Sales (S)
- 20
- Companies
- 1
- Name as filed
- GOLDSMITH MARK A
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Director, Officer · See Remarks | 21 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Revolution Medicines, Inc. | S | 213 | $195.01 | 267,117 | Form 4 |
| 2026-09-16 | Revolution Medicines, Inc. | S | 13,775 | $199.3 | 253,342 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 245 | $211.47 | 61,551 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 229 | $211.46 | 61,550 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 126 | $210.4 | 61,779 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 1,405 | $209.27 | 61,905 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 937 | $208.36 | 63,310 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 177 | $207.25 | 64,247 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 127 | $212.06 | 61,424 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 126 | $212.06 | 61,424 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | M | 80,000 | $4.73 | 347,330 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 5,128 | $207.23 | 342,202 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 24,917 | $208.37 | 317,285 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 35,938 | $209.26 | 281,347 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 3,813 | $210.25 | 277,534 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 6,583 | $211.33 | 270,951 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 3,621 | $212.08 | 267,330 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 190 | $207.25 | 64,234 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 951 | $208.36 | 63,283 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 1,351 | $209.28 | 61,932 | Form 4 |
| 2026-08-21 | Revolution Medicines, Inc. | S | 136 | $210.4 | 61,796 | Form 4 |
Questions
What stock did Goldsmith Mark A buy or sell?
Goldsmith Mark A reported 21 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 20 sales ($20.8M), across 1 company.
Is Goldsmith Mark A the same person as other filers with this name?
This page covers SEC CIK 1246842 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/goldsmith-mark-a-1246842.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.